Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...
(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the ...
July 3 (Reuters) - AstraZeneca (AZN.L), opens new tab is in talks with Summit Therapeutics (SMMT.O), opens new tab to license an experimental lung-cancer drug under a deal worth as much as $15 billion ...
Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Pascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and ...
The number of therapies developed in China has doubled in recent years, and approximately one-third of the global licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results